Info
Insider Ownership

Insider Trading & Ownership of Scott Requadt

Location: Cambridge, MA
Summary: The estimated net worth of Scott Requadt is at least $17,468,591 dollars as of 15 Oct 2025. Scott Requadt is the Former Chief Executive Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $17.47M.
Signature: /s/ Scott Requadt
All Insider Reports: All Insider Reports

Notify me when Scott Requadt files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Scott Requadt

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRML	Tourmaline Bio, Inc.	Former Chief Executive Officer	$17,468,591			03 Jul 2023
EPIX	ESSA Pharma Inc.	Director	$0			09 Oct 2025

Insider Transactions Reported by Scott Requadt:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.